Article
Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes.
Haematologica - 1 Nov 2013
Merker Jason D, Roskin Krishna M, Ng Dana, Pan Cuiping, Fisk Dianna G, King Jasmine J, Hoh Ramona, Stadler Michael, Okumoto Lawrence M, Abidi Parveen, Hewitt Rhonda, Jones Carol D, Gojenola Linda, Clark Michael J, Zhang Bing, Cherry Athena M, George Tracy I, Snyder Michael, Boyd Scott D, Zehnder James L, Fire Andrew Z, Gotlib Jason
Abstract excerpt
In order to identify novel somatic mutations associated with classic BCR/ABL1-negative myeloproliferative neoplasms, we performed high-coverage genome sequencing of DNA from peripheral blood granulocytes and cultured skin fibroblasts from a patient with MPL W515K-positive primary myelofibrosis. The primary myelofibrosis genome had a low somatic mutation rate, consistent with that observed in similar hematopoietic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
